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Abstract
Background
Adverse drug events (ADEs) impose a major clinical and cost burden on acute hospital ser-
vices. It has been reported that medicines reconciliation provided by pharmacists is effective
in minimizing the chances of hospital admissions related to adverse drug events.
Objective
To update the previous assessment of pharmacist-led medication reconciliation by restrict-
ing the review to randomized controlled trials (RCTs) only.
Methods
Six major online databases were sifted up to 30 December 2016, without inception date
(Embase, Medline Ovid, PubMed, BioMed Central, Web of Science and Scopus) to assess
the effect of pharmacist-led interventions on medication discrepancies, preventable adverse
drug events, potential adverse drug events and healthcare utilization. The Cochrane tool
was applied to evaluate the chances of bias. Meta-analysis was carried out using a random
effects model.
Results
From 720 articles identified on initial searching, 18 RCTs (6,038 patients) were included.
The quality of the included studies was variable. Pharmacists-led interventions led to an
important decrease in favour of the intervention group, with a pooled risk ratio of 42% RR
0.58 (95% CI 0.49 to 0.67) P<0.00001 in medication discrepancy. Reductions in health-
care utilization by 22% RR 0.78 (95% CI 0.61 to 1.00) P = 0.05, potential ADEs by10%
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RR 0.90 (95% CI 0.78 to 1.03) P = 0.65 and preventable ADEs by 27% RR 0.73 (0.22 to
2.40) P = 0.60 were not considerable.
Conclusion
Pharmacists-led interventions were effective in reducing medication discrepancies. How-
ever, these interventions did not lead to a significant reduction in potential and preventable
ADEs and healthcare utilization.
Introduction
Adverse drug events (ADEs) impose a major clinical [1–2] and cost burden on acute hospital
services [3]. An ADE, defined as a drug-related injury to a patient, includes physical and mental
harm, or loss of function [4]. Patients are at a greater risk of experiencing an ADE through med-
ication discrepancies to some extent during their movement within or out of hospital [5–8].
Medication discrepancies are termed as any unclear changes that have been documented in the
medication lists of patients during their movement across different sites of care [9]. Around
one-third of these discrepancies have the potential to harm the patients [6], which subsequently
accounts for increased utilisation of healthcare resources [10–11]. Medication reconciliation
has been considered as an effective strategy to minimise the risk of medication discrepancies
[12] that may be potentially associated with ADEs. Medication reconciliation refers to the “pro-
cess of identifying the most accurate list of all medications a patient is taking . . . and using this
list to provide correct medications for patients anywhere within the health system” [13].
The process of medication reconciliation should account for any alterations made in the
medications taken by patients and should make sure that patients or their carers have been
made aware of these alterations [13]. Although, medication reconciliation does not have an
impact on mortality [14], it can significantly reduce prescribing error rates [15], medication
discrepancies [16–17] and unscheduled drug related visits to hospital [18].
Recent systematic reviews and meta-analysis suggest that medication reconciliation pro-
vided by pharmacists is effective in decreasing the risk of medication discrepancies [16–17, 19]
adverse drug event-related hospital revisits, Emergency Department (ED) visits and admis-
sions [20]. These studies have however; have been limited by the inclusion of observational
studies [16–17, 19–20], evidence of substantial heterogeneity between the included studies
[19–20] and involvement of multifaceted medication reconciliation strategies [16–17]. Fur-
thermore, there is a need to update the current evidence on the effectiveness of pharmacist-led
medication reconciliation in hospital settings. The aim of this systematic review and meta-
analysis is to update the existing evaluation of the impact of pharmacist-led medication recon-
ciliation on healthcare outcomes by restricting the review to randomized controlled trials
(RCTs) only and by considering pharmacists interventions as medication reconciliation, tai-
lored patient counselling, provision of telephonic consultation with patients post-hospital dis-
charge and creation of post-discharge medication lists.
Materials and methods
Eligibility criteria
Articles were included on the basis following criteria.
Study designs. RCTs evaluating the effect of pharmacists based medicines reconciliation
on: 1) medication discrepancies OR 2) potential adverse drug events OR 3) preventable adverse
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drug events OR 4) healthcare utilization post hospital discharge. Bates criteria [7] was used to cat-
egorize ADEs into preventable and potential ADEs. Although, pharmacists-led medication
review has a similar approach to medicines reconciliation and some of their activities overlap
with each other, the reviewers only considered activities related to medicine reconciliation in this
review. The reviewers also excluded study protocols, non-RCTs, conference abstracts, non-hos-
pital settings, non-pharmacist-intervention providers, and studies with different study outcomes.
Participants. It was expected that most of the RCTs eligible for inclusion in the review
would include adult participants only. Therefore, participants included in the review were
adults (18 years or older).
Comparators. RCTs were included if they had an intervention group receiving the inter-
vention and a control group receiving standard or routine care. Usual or standard care was
considered as care without the provision of medication reconciliation or provision of medica-
tion reconciliation by a healthcare professional other than the pharmacist.
Timing. There was no restriction on the duration of follow-up for the studies.
Setting. Hospital settings including all care of transitions within the hospital.
Language. Articles published in the English language only were included.
Information sources
Six major online databases were sifted up to 30 December 2016, without inception date
(Embase, Medline Ovid, PubMed, BioMed Central, Web of Science and Scopus). Articles
were retrieved up to 30th December 2016. Search terms included: “medication reconcilia-
tion”, “pharmacist”, “pharmacist-led” and “randomised controlled trials” (see Appendix 1
for the complete search strategy).
Furthermore, reference lists of all included articles were sifted to identify any relevant arti-
cle. In addition, searches were also conducted in Cochrane to ensure that any eligible RCT had
not been missed.
Selection process and quality assessment
Two reviewers (MB, MM) screened the titles and abstracts of all eligible articles. Articles that
qualified for inclusion were retrieved as full-text articles to finalize their inclusion. The Coc-
hrane Risk of Bias tool [21] was used to assess the quality of included studies.
Data collection process
Reviewer AS independently extracted data, and EC examined all extraction sheets to ensure
their accuracy (see Table 1 for characteristics of included articles).
Data items
A descriptive analysis of the included RCTs was carried out followed by meta-analyses. Due to
expected variations in the study population of the included RCTs and their methods of mea-
suring healthcare outcomes, a random-effects model was used (Rev-Man version 5.2). How-
ever, fixed-effect model was also used to validate the results. Heterogeneity was estimated by
Cochrane’s test and further analysed using I2.
Outcomes and prioritisation
Four outcomes were assessed with equal priority in the review, and these were:
• Medication discrepancies, termed as any unclear changes that have been documented in the
medication lists of patients during their movement across different sites of care [9].
Pharmacists-led medicines reconciliation
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Table 1. Characteristic of included studies.
Author, year
of
publication
Study
setting
Study
design
Sample
size
Key components of pharmacist
intervention
Outcomes assessed Intervention
provider
Comparison
Stowasser et al
2002
Hospital RCT 240 Medication liaison service-medication
history confirmation with community
healthcare professionals (telephone,
faxing, 30 days post-follow-up)
Mortality, readmission, ED visit, Pharmacist Usual care (did not
receive medication
liaison service)
Bolas et al
2004
Hospital RCT 164 Medication history taking, medication
reconciliation, patient counselling,
communication with outpatient
providers
Medication discrepancies,
healthcare utilization
Pharmacists Usual care (nurses)
Nickerson
et al
2005
Hospital RCT 253 Medication reconciliation, patient
counselling, communication with
outpatient providers
Medication discrepancies Pharmacists Usual care (nurses)
Schnipper
et al
2006
Hospital RCT 178 Medication reconciliation, patient
counselling, communication with
outpatient providers
ADEs, healthcare utilization Clinical
pharmacists
Usual care (ward
based pharmacists
and nurses)
Kwan et al
2007
Hospital RCT 464 Medication history taking, medication
reconciliation
Medication discrepancies,
potential ADEs
Pharmacists Usual care (nurses)
Scullin et al
2007
Hospital RCT 762 Integrated medicines management
service admission and discharge,
medicine reconciliation, inpatient
medication review and counselling,
telephone follow up
Length of hospital stay,
readmission
Pharmacist Usual care (did not
receive integrated
medicines
management)
Gillespie et al
2009
Hospital RCT 400 Medication reconciliation, patient
counselling, communication with
outpatient providers, medication history
taking, post-discharge communication
with the patients.
Healthcare utilization Pharmacists Usual care (no
involvement of
pharmacists)
Koehler et al
2009
Hospital RCT 41 Medication reconciliation, patient
counselling, communication with
outpatient providers, medication history
taking
Healthcare utilization Pharmacists Usual care (ground
nursing staff)
Eggink et al
2010
Hospital RCT 85 Medication reconciliation, patient
counselling, communication with
outpatient providers, medication history
taking
Medication discrepancies,
potential ADEs
Pharmacists Usual care (Nurses
and physicians
routine activities)
Lisby et al
2010
Hospital RCT 99 Medication reconciliation, patient
counselling, communication with
outpatient providers, medication history
taking
Healthcare utilization, ADEs Pharmacist Usual care (junior
physicians)
Marotti et al
2011
Hospital RCT 357 Medication history taking, medication
reconciliation
Mean no. of missed medication
doses
Pharmacist Usual care
(Physicians)
Kripalani et al
2012
Hospital RCT 862 Pharmacist-assisted medication
reconciliation, tailored inpatient
counselling by a pharmacist, provision
of low-literacy adherence aids, and
individualized telephone follow-up after
discharge
Clinically important medication
errors, ADEs and potential ADEs
Pharmacists Usual care
Becerra-
Camargo et al
2013
Hospital RCT 242 Pharmacist acquired a standardised,
comprehensive medication history,
conducted telephone interviews with
caregivers or family members, and
verified with the patient if any
medication changes had been made
since their 24 hours in an ED.
Medication discrepancy at
admission, characteristics and
clinical severity of such
medication discrepancies.
Pharmacists Usual care
Hawes et al
2014
Hospital RCT 61 Post-discharge medication
reconciliation
Readmission, ED visit,
readmission and or ED visit
Pharmacist Usual care (with no
pharmacist
intervention)
(Continued)
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• Potential adverse drug events, termed as adverse drug events with potential to cause injury
[7].
• Preventable adverse drug events, termed as adverse drug events that were preventable [7].
• Healthcare utilization, termed as utilization of healthcare resources through drug-related
Emergency Department visits or hospital readmissions [10].
Results
A total of 732 articles were identified initially (see Fig 1 for Prisma flow diagram) that included
720 from electronic databases and 12 from reference lists of previous reviews. Of these 732 arti-
cles, eight duplicates were removed and remaining 724 articles were assessed for eligibility. After
the removal of 567 articles with irrelevant titles, 157 articles were assessed at abstract level. After
the removal of 100 abstracts that did not meet the eligibility criteria, 57 full-text articles were
assessed for further eligibility. Of these 57 full-text articles, 39 failed to meet the eligibility criteria.
Reasons for their removal included: not RCTs, different study settings, intervention not provided
by pharmacists, different study outcome, studies not defining pharmacist roles and studies with
published protocol only. Finally, 18 RCTs contributed to the systematic review [22–39].
Study quality
Only eight (44%) of the 18 articles reported allocation concealment [22–24, 31–33, 35–36]. It
was not clear in the remaining 10 articles whether they had used allocation concealment (see
Table 1. (Continued)
Author, year
of
publication
Study
setting
Study
design
Sample
size
Key components of pharmacist
intervention
Outcomes assessed Intervention
provider
Comparison
Farris et al
2014
Hospitals RCT 945 Created discharge care plan, telephoned
patients 3–5 days post- discharge to
evaluate adherence and new side effects,
identified any medication-related
problems and reported to the physicians.
Medication appropriateness
index (MAI). Adverse events,
adverse drug events and post-
discharge healthcare utilization
Pharmacists Usual care
Aag et al
2014
Hospital RCT 201 Performed structured patient interview
(to reveal all type of medicines). Also
included a checklist with specific
questions
Differences in the outcomes of
medication reconciliation(MR)
when performed by clinical
pharmacists compared to nurses
Clinical
pharmacists
Nurses
Farley et al
2014
Hospital RCT 592 Minimal intervention group: clinical
pharmacist case managers gave advice to
patients on medication reconciliation,
patient education on discharge
medication.
Enhanced intervention group: all the
previously mentioned care along with
discharge care plan and follow-up phone
call from the clinical pharmacist case
managers 3–5 days after discharge.
Medication discrepancies Pharmacist Usual care
Becerra-
Camargo et al
2015
Hospital RCT 270 Held a standardised, medication history
interview with the patient during ED
admission, conducted telephone
interviews with caregivers or family
members, reviewed medical charts,
verified any changes with patients.
Percentage of potential ADEs Pharmacists Usual care
https://doi.org/10.1371/journal.pone.0193510.t001
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Fig 2A and 2B). Only six (33%) articles reported details of missing outcome data [24–25, 29,
32–33, 35] while only seven (39%) articles reported power calculations [22–23, 29, 32–34, 37].
Study characteristics
All 18 included articles were RCTs that were conducted in hospital settings. Included RCTs
were conducted in the United States [27–28, 30–32, 37], Canada [33, 36], Australia [35, 39],
Colombia [23–24], Ireland [25, 38], Norway [22], Netherlands [26], Sweden [29] and Denmark
[34].The RCTs included 6,038 patients, with a population range of 41 [31] to 945 [28]. All 18
Fig 1. Prisma flow diagram representing the selection process of articles included in the review.
https://doi.org/10.1371/journal.pone.0193510.g001
Pharmacists-led medicines reconciliation
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articles had an intervention group that received one or more of the pharmacists-led interven-
tions including: medication history taking, medication reconciliation, patient counselling, cre-
ation of post-discharge medication lists compared with a control group receiving usual care
(see Table 1 for characteristics of included studies).
Impact of pharmacist interventions on outcome measures
Of the 18 RCT, 10 were included in the meta-analysis [23, 26, 27–28, 31–34, 37–38]. All 10
RCTs included in the meta-analysis employed three similar pharmacist-led interventions:
medication reconciliation, tailored patient counselling and provision of telephonic advice to
patients post-hospital discharge. Absence of quantitative study outcome data on the reviewed
study outcomes for example in studies [22, 24, 35] and use of multidisciplinary interventions
including general practitioners and community pharmacists, for example in study [39] were
reasons to remove the remaining eight RCTs from meta-analysis [22, 24–25, 29–30, 35–36,
39].
Fig 2. (a) Risk of bias graph: review authors’ judgements about each risk of bias item presented as percentages across all included studies. 2 (b) Risk of bias summary:
review authors’ judgements about each risk of bias item for each included study.
https://doi.org/10.1371/journal.pone.0193510.g002
Pharmacists-led medicines reconciliation
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Medication discrepancy. Four of the seven RCTs that reported data on medication dis-
crepancy were included in the meta-analysis [23, 26–27, 33]. Meta-analysis of data from four
RCTs (1,102 patients) reported an important reduction in favour of the intervention group
with a pooled risk ratio of 42% RR 0.58 (95% CI 0.49 to 0.67) P<0.00001. No difference was
reported between the effects of random and fixed-effect model meta-analysis. Heterogeneity
among the RCTs was low (χ2 = 4.17, d.f. = 3, P = 0.24, I2 = 28%; Fig 3A).
Potential ADEs. Three of the four RCTs that reported data on potential ADEs were
included in the meta-analysis [28, 37–38]. Meta-analysis of these RCTs (1,885 patients) showed
a small reduction in favour of the intervention group, with a pooled risk ratio of 10% RR 0.90
(95% CI 0.78 to 1.03) P = 0.65. There was no heterogeneity among the RCT (χ2 = 0.69, d.f. = 3,
P = 0.88, I2 = 0%; Fig 3B).
Preventable ADEs. Three studies reported data on preventable ADEs and were included
in the meta-analysis [28, 32, 37]. Meta-analysis of these three RCTs (1,985 patients) showed a
small reduction in favour of the intervention group, with a pooled risk ratio of 27% RR 0.73
(95% CI 0.22 to 2.44) P = 0.60. Heterogeneity among the RCTs was low to moderate
(χ2 = 5.94, d.f. = 3, P = 0.11, I2 = 50%; Fig 3C).
Healthcare utilization post-hospital discharge. Of the eight studies that reported data
on healthcare utilisation, four were included in the meta-analysis [31, 34, 37–38]. Meta-analy-
sis of four studies (1,080 patients) showed a non-significant reduction in favour of the inter-
vention group, with a pooled risk ratio of 22% RR 0.78 (95% CI 0.61 to 1.00) P = 0.05. No
difference was reported between the effects of random and fixed-effect model meta-analysis.
There was no heterogeneity among the RCTs (χ2 = 2.17, d.f. = 3, P = 0.54, I2 = 0%; Fig 3D).
Sensitivity analysis for the study outcomes
A step-wise exclusion of studies included in the meta-analysis did not make any significant dif-
ference in the results of any outcomes.
Discussion
The findings of this systematic review show that, compared with usual care, active interventions
by pharmacists including medication reconciliation, tailored patient counselling, and provision
of telephonic consultation with patients following hospital discharge were associated with clini-
cally important reduction in medication discrepancies. There was a non-significant reduction in
favour of the intervention group for potential and preventable ADEs and healthcare utilization.
Previous reviews have assessed the impact of pharmacist interventions on clinical outcomes
across various hospital transitions by including observational studies [16–17, 19–20] and by
involving multifaceted interventions [16–17]. This study has updated the existing evaluation
of the impact of pharmacist-led medication reconciliation on healthcare outcomes by includ-
ing a further seven RCTs that were not referenced in the last published review conducted by
Mekonnen et al [20].
The findings of this review suggest that interventions provided by pharmacists led to impor-
tant reductions in medication discrepancies across a wide range of international geographical
regions from North and South America to Europe and Australia. These findings are similar to
the findings of the previous review [20] that reported important reductions in medication dis-
crepancies as a result of pharmacist interventions. Medication discrepancies can occur at either
hospital admission stage or at discharge [40–41] and can contribute to potentially harmful ad-
verse events. A study involving patients 65 years and older reported that 14.3% of the patients
who had one or more medication discrepancy post-hospital discharge were re-admitted to the
hospital after one month compared to 6.1% of patients with no discrepancy [42]. The decrease
Pharmacists-led medicines reconciliation
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in medication discrepancies reported in this review suggests the significance of collecting accu-
rate and complete medication histories in reducing the incidence of potential adverse events.
Completion of accurate and comprehensive medication histories across all hospital transi-
tions is also helpful in reducing healthcare utilizations following hospital discharge as reported
in this review. All eight studies that assessed the impact of pharmacist-led interventions on
healthcare utilization post-hospital discharge reported reduction in healthcare utility by reduc-
ing hospital readmissions and Emergency Department visits. These findings are in contrast to
the findings of a previous review by Mueller et al [16], where only two of the eight studies
Fig 3. Forest plot comparisons of experimental (intervention) vs. control groups in four studies for medication discrepancy (A) three studies for potential ADEs
(B) three studies for preventable ADEs (C) and four studies for healthcare utilization post-hospital discharge (D). Pharmacists-led interventions included medicine
reconciliation and tailored patient counselling post hospital discharge. Farley [27] and Farris [28] used two tiers of pharmacist interventions: enhanced and
minimal.
https://doi.org/10.1371/journal.pone.0193510.g003
Pharmacists-led medicines reconciliation
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reported reduction in healthcare utilization following hospital discharge. However, that review
used multifaceted interventions related to information technology, pharmacist-based and other
types. A study conducted in Sweden that included 368 patients reported that patients who re-
ceived pharmacist interventions experienced an overall 16% reduction in hospital visits includ-
ing a 47% reduction in visits to the Emergency Department [29]. Furthermore, pharmacist
interventions were also associated with an 80% reduction in drug-related readmissions.
The evidence presented in this review that is consistent with previous reviews [16–17, 19–
20] suggests the important role of pharmacists in taking accurate medication history across
various hospital transitions. Pharmacists’ increased knowledge and acquaintance with the me-
dications allows them to extend support to other healthcare professionals including doctors
and nurses by acquiring precise and complete medication histories from the patients [43–44].
For example, a study by Kwan et al [33] reported that pharmacists who interviewed patients as
part of medication reconciliation identified more medications per patient as compared to doc-
tors and nurses. However, owing to the extensive involvement of pharmacists in other phar-
macy services, they may not be available to conduct medicine reconciliation at all times. In
such busy times, senior pharmacy technicians along with nurses should continue to perform
the process of medicines reconciliation.
There were limitations in this review. The reviewers did not include unindexed and unpub-
lished research. Studies were of variable quality. Within our efforts to limit heterogeneity, we
included studies in the meta-analysis that had similar study design and used similar interven-
tions, yet low to moderate heterogeneity between the studies included for the assessment of
some of the outcomes suggests that medication reconciliation based interventions are complex.
Some of the studies used a coordinated model of care that may explain the complexity of these
interventions. For example, a study by Stowasser et al [39] employed a medication liaison ser-
vice where clinical pharmacists, in consultation with general practitioners, community pharma-
cists and hospital staff, prepared a comprehensive medication list at both hospital admission
and prior to hospital discharge. Patients who received the medication liaison service experi-
enced better patient outcomes including a significant reduction in hospital readmissions and
healthcare professional visits per patient.
Conclusions
Pharmacists-led interventions were effective in reducing medication discrepancies. However,
these interventions did not lead to a significant reduction in potential and preventable ADEs
and healthcare utilization. The quality of studies included in this review was variable and
therefore the findings of this review must be interpreted with caution. Future studies are
required to evaluate the impact and sustainability of pharmacist-led interventions on health-
care outcomes in the long term.
Appendix 1: Search strategies used in the major electronic
databases
Embase:
1. Medicine reconciliation.mp.
2. Medicine reconciliation Or exp medicines reconciliation/
3. 1 or 2
4. Exp pharmaceutical care/ or exp pharmacy/ or exp pharmacist/
5. pharmac.mp.
Pharmacists-led medicines reconciliation
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6. 4 or 5
7. Exp pharmacist/ or pharmacis.mp.
8. Intervention.mp.
9. 3 and 6 and 7 and 8
10. limit 9 to (English language and randomized controlled trial and (adult<18 to 64 years>
or aged<65+ years>)
Medline Ovid:
1. Medicine reconciliation.mp.
2. Medicine reconciliation Or exp medicines reconciliation/
3. 1 or 2
4. Exp pharmaceutical care/ or exp pharmacy/ or exp pharmacist/
5. pharmac.mp.
6. 4 or 5
7. Exp pharmacist/ or pharmacis.mp.
8. Intervention.mp.
9. 3 and 6 and 7 and 8
10. limit 9 to (English language and randomized controlled trial and (adult<18 to 64 years>
or aged<65+ years>)
Web of Science:
1. Pharmacist OR pharmacists OR pharmaceutical AND
2. Medicines reconciliation
Pubmed:
1. Pharmacists OR pharmacist interventions
2. Medicines reconciliation
3. RCTs
Scopus:
Pharmacist OR pharmacists OR pharmaceutical AND
1. Medicines reconciliation AND
RCTs
Biomed Central:
1. Pharmacists interventions ALL WORDS
Pharmacists-led medicines reconciliation
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2. Medicines reconciliation AND
3. Randomised controlled trial AND
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